II. Организационные аспекты внедрения протокола

17. Список разработчиков:

18. Рецензенты:

19. Указание условий пересмотра протокола: Следующий пересмотр: не позже чем через 2 года с даты настоящего утверждения.

20. Список использованной литературы:

1. Levey AS, Eckardt KU, Tsukamoto Y, et al. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2005; 67: 2089.

2. KDOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification. Am J Kidney Dis, 2002, T.2 Suppl.1. P.1 - 246

3. Jander A, Nowicki M, Tkaczyk M et al. Does a late referral to a nephrologist constitute a problem in children starting renal replacement therapy in Poland? – A nationwide study. Nephrol Dial Transplant. 2006 Apr; 21(4): 957-961.

4. Wuhl E, Schaefer F. Therapeutic strategies to slow chronic kidney disease progression. Pediatr Nephrol 2008; 23: 705-716

5. Mattoo TK. Epidemiology, risk factors, and etiology of hypertension in children and adolescents. In UpToDate Online 16.1. UpToDate1, Inc. Niaudet P (eds.). 2008

6. Association IPH: Blood Pressure Limits Chart. In, 2008 https://www.pediatrichypertension.org/BPLimitsChart.pdf

7. Strict blood-pressure control and progression of renal failure in children. ESCAPE Trial Group, Wuhl E, Trivelli A, Picca S et al. N Engl J Med. 2009 Oct22; 361(17): 1639-50

8. Rene G. VanDeVoorde, Bradley A. Warady. Management of Chronic Kidney Disease, from Pediatric Nephrology; 1676-1677; Springer 2009

9. Clinical practice recommendations for anemia in chronic kidney disease in children. Am J Kidney Dis 2006; 47: 86–108.

10. Rene G. VanDeVoorde, Bradley A. Warady. Management of Chronic Kidney Disease, from Pediatric Nephrology; 1666-1670; Springer 2009

11. Boehm M, Riesenhuber A, Winkelmayer WC, Arbeiter K, Mueller T, Aufricht C. Early erythropoietin therapy is associated with improved growth in children with chronic kidney disease. Pediatr Nephrol. 2007 Aug; 22(8): 1189-93

12. Jabs K. the effect of recombinant human erythropoietin on growth and nutritional status. Pediatr Nephrol 1996; 10: 324-327

13. Gerson A, Hwang W, Fiorenza J et al. Anemia and health-related quality of life in adolescents with chronic kidney disease. Am J Kidney Dis. 2004; 44: 1017-1023

14. Об утверждении номенклатуры, правил заготовки, переработки, хранения, реализации крови и ее компонентов, а также правил хранения, переливания крови, ее компонентов и препаратов. Приказ и.о. министра здравоохранения Республики Казахстан от 6 ноября 2009 года №666.

15. Strivaths PR, Wong C, Goldstein SL. Nutrition aspects in children receiving maintenance hemodialysis: impact on outcome. Pediatr Nephrol 2008 Feb 22

16. Foster BJ, McCauley L, Mak RH. Nutrition in infants and very young children with chronic kidney disease. Pediatr Nephrol. 2011 Aug 28.

17. Wingen AM, Fabian-Bach C, Schaefer F et al. Randomised multi-centre study of a low-protein diet on the progression of chronic renal failure in children. European Study Group of Nutritional Treatment of Chronic Renal Failure in Childhood. Lancet 1997; 349: 1117-1123

18. Pereira AM, Hamani N, Nogueira PC, Carvalhaes JT. Oral vitamin intake in children receiving long-term dialysis. J Ren Nutr. 2000 Jan; 10(1): 24-9

19. Кучер А.Г., Каюков И.Г., Есаян Е.М., Ермаков Ю.А. Настольная книга по птианию для больных с хронической почечной недостаточностью. Санкт-Петербург, 2004.

20. Lesley Ress, Vanessa Shaw. Nutrition in children with CRF and on dialysis. Pediatr Nephrol. 2007; 22: 1689 - 1702

21. Mehls O, Wuhl E, Tonshoff B et al. Growth hormone treatment in short children with chronic kidney disease. Acta Paediatr. 2008 Sep; 97(9): 1159-64

22. Katherine Wesseling-Perry, Isidro B.Salusky. chronic Kidney Disease Mineral ans Bone Disorder, from Pediatric Nephrology; 1755 – 1783; Springer 2009

23. National Kidney Foundation. K/DOQI clinical pracrice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis. 2003 Oct; 42(4 Suppl 3): S1-201

24. Shah SN, Abramowitz M, Hostetter TH et al. Serum bicarbonate level and the ptogression of Kidney Disease: A Cohort Study. Am J Kidney Disease, Vol 54 No 2, 2009: 270-277

25. Clinical practice guidelines for nutrition in chronic renal failure. K/DOQI, National Kidney Foundation. Am J Kidney Dis 2000; 35: S1–140.

26. Seikaly MG, Salhab N, Browne R. Patterns and time of initiation of dialysis in US children. Pediatr Nephrol 2005; 20: 982-988

27. National Kidney Foundation. K/DOQI. 2006 updates clinical practice guidelines and recommendations. https://www.kidney.org/professionals/kdoqi/pdf/12-50-0210_JAG_DCP_Guidelines-HD_Oct06_SectionA_ofC.pdf

28. KDIGO for Anemia in Cronic Kidney Disease. 2012

29. Coyne D W Hepcidin: clinical utility as a diagnostic tool and therapeutic target. Kidney International (2011) 80, 240–244; doi: 10.1038/ki.2011.141; published online 15 June 2011

30. Kanbay M, Perazella M, Kasapoglu B, Koroglu M, Covic A. Erythropoiesis Stimulatory Agents-Resistant Anemia in Dialysis Patients // Blood Purification 2010; 29: 1-12

31. Kadiroglu AK, Yilmaz ME, Sit D, Kara IH, Isikoglu B. The evaluation of postdialysis L-carnitine administration and its effect on weekly doses of rHuEPO in hemodialysis patients // Ren Fail 2005; 27: 367-372

32. Calo LA, Davis PA, Pagnin E, Bertipaglia L, Naso A, Piccoli A, Corradini R. L-carnitine-mediated improved response to erythropoietin involves induction of haem oxygenase-1 // Nephrol Dial Transplant 2008; 23: 890-895